Skip to main content

CVA Family Office, LLC

Family Office

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1802084 DENVER, CO

Position in REGN

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$89,166
-$60,726 QoQ
Shares Held
143
-26.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,098
of 1,329 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CVA Family Office, LLC holds $743,661 across 48 Biotechnology names. REGN ranks #4 (12.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 REGN
Regeneron Pharmaceuticals, Inc.
This page
143 $89,166

All Filings in REGN

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $89,166 143
2026-03-31 $149,892 194
2025-12-31 $111,921 145
2025-09-30 $84,340 150
2025-06-30 $73,500 140
2025-03-31 $104,647 165
2024-12-31 $109,698 154
2024-09-30 $152,429 145
2024-06-30 $146,093 139
2024-03-31 $132,823 138
2023-12-31 $120,325 137
2023-06-30 $88,380 123
2023-03-31 $101,065 123
2022-12-31 $86,578 120
2022-09-30 $79,220 115
2022-06-30 $56,157 95
2022-03-31 $101,270 145
2021-12-31 $59,994 95
2021-06-30 $53,061 95
2021-03-31 $33,119 70